CCL20 expression is elevated in inflammatory bowel disease and attenuated by vitamin D metabolites
Abstract Intestinal epithelial overexpression of the Th17 cell chemoattractant CCL20 is implicated in inflammatory bowel disease and influenced by NOD2 mutations in Crohn’s disease. Vitamin D metabolites have been shown to ameliorate inflammatory bowel disease. Considering NOD2 mutations in Crohn’s...
Saved in:
| Main Authors: | Johannes Stallhofer, Felix Reichl, Michael Lauseker, Lisa Waldenmaier, Helga Paula Török, Julia Mayerle, Torsten Olszak, Fabian Schnitzler, Iris Frasheri, Simone Breiteneicher, Stephan Brand, Andreas Stallmach, Julia Diegelmann, Florian Beigel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-05094-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Betulinic Acid and Ursolic Acid on IL-17-Induced CCL20 Release in Normal Human Epidermal Keratinocytes
by: Anna Arai, et al.
Published: (2025-07-01) -
Exosome Secretion Regulation in Mice with Acute Lung Injury
by: Jie HH, et al.
Published: (2025-06-01) -
A local-global principle for unipotent characters
by: Damiano Rossi
Published: (2024-01-01) -
Maraviroc/cisplatin combination inhibits gastric cancer tumoroid growth and improves mice survival
by: Bárbara Mora-Lagos, et al.
Published: (2025-01-01) -
Progress of CCL20-CCR6 in the airways: a promising new therapeutic target
by: Ya -Jing Li, et al.
Published: (2024-12-01)